SEC Company Response from Repare Therapeutics Inc. (RPTX) (CIK 0001808158) — Jun 16, 2020
Repare Therapeutics Inc. (RPTX) (CIK 0001808158)
Date: June 16, 2020 · CIK: 0001808158 · Accession: 0001193125-20-170404
AI Filing Summary & Sentiment
File numbers found in text: 333-238822
Letter
REPARE THERAPEUTICS INC.
7210 Frederick-Banting, Suite 100
St-Laurent, Québec H4S 2A1
Canada
June 16, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Tracey McKoy
Ms. Kate Tillan
Mr. Tim Buchmiller
Ms. Celeste Murphy
Re: Repare Therapeutics Inc.
Registration Statement on Form S-1 (File No. 333-238822)
Acceleration Request
Requested Date: Thursday, June 18, 2020
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentleman:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Repare Therapeutics Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended to date, the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern time, on June 18, 2020, or as soon thereafter as possible, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the Staff. The Registrant hereby authorizes each of Divakar Gupta and Courtney Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Divakar Gupta of Cooley LLP at +1 212 479 6474 and in his absence, Courtney Thorne of Cooley LLP at +1 617 937 2318.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement.
[Signature page follows]
Very truly yours,
Repare Therapeutics Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP REPARE THERAPEUTICS INC. 7210 Frederick-Banting, Suite 100 St-Laurent, Québec H4S 2A1 Canada June 16, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Tracey McKoy Ms. Kate Tillan Mr. Tim Buchmiller Ms. Celeste Murphy Re: Repare Therapeutics Inc. Registration Statement on Form S-1 (File No. 333-238822) Acceleration Request Requested Date: Thursday, June 18, 2020 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentleman: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Repare Therapeutics Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended to date, the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern time, on June 18, 2020, or as soon thereafter as possible, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the Staff. The Registrant hereby authorizes each of Divakar Gupta and Courtney Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Divakar Gupta of Cooley LLP at +1 212 479 6474 and in his absence, Courtney Thorne of Cooley LLP at +1 617 937 2318. Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement. [Signature page follows] Very truly yours, Repare Therapeutics Inc. /s/ Lloyd M. Segal By: Lloyd M. Segal Title: President and Chief Executive Officer cc: Lloyd M. Segal, Repare Therapeutics Inc. Steve Forte, Repare Therapeutics Inc. Marc A. Recht, Cooley LLP Ryan S. Sansom, Cooley LLP Courtney T. Thorne, Cooley LLP Mitchell S. Bloom, Goodwin Procter LLP Seo Salimi, Goodwin Procter LLP [Signature Page to Company Acceleration Request]